Promoting pyroptosis—an inflammatory form of programmed cell death—has become a promising treatment strategy for cancer. In research published in The FASEB Journal, investigators purified a long-chain sugar molecule, or exopolysaccharide, from deep-sea bacteria and demonstrated that it triggers pyroptosis to inhibit tumor growth.
The compound, called EPS3.9, consists of mannose and glucose and is produced by the Spongiibacter nanhainus CSC3.9 bacterial strain and other members of the genus Spongiibacter. Mechanistic analyses showed that EPS3.9 can directly target 5 membrane phospholipid molecules and exert tumor toxicity by stimulating pyroptosis in human leukemia cells. EPS3.9 also had significant anti-tumor effects in the mice with liver cancer and activated anti-tumor immune responses.
“Our work not only provides a theoretical basis for developing more carbohydrate-based drugs but also highlights the importance of exploring marine microbial resources,” said corresponding author Chaomin Sun, PhD, of the Chinese Academy of Sciences.
URL upon publication: https://onlinelibrary.wiley.com/doi/10.1096/fj.202500412R
Additional Information
NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. For more information or to obtain a PDF of any study, please contact: Sara Henning-Stout, newsroom@wiley.com.
About the Journal
The FASEB Journal, the flagship publication of the Federation of American Societies for Experimental Biology (FASEB), leads in publishing groundbreaking multidisciplinary research in biology and biomedical sciences. It spans all levels of biological organization, from molecular to population studies. The journal drives advances in basic, translational, pre-clinical, and early clinical research. Known for its rigorous peer-review process, The FASEB Journal is dedicated to advancing high-quality scientific discoveries and shaping the future of science.
About Wiley
Wiley is one of the world’s largest publishers and a trusted leader in research and learning. Our industry-leading content, services, platforms, and knowledge networks are tailored to meet the evolving needs of our customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. We empower knowledge-seekers to transform today’s biggest obstacles into tomorrow’s brightest opportunities. For more than two centuries, Wiley has been delivering on its timeless mission to unlock human potential. Visit us at Wiley.com. Follow us on Facebook, X, LinkedIn and Instagram.
Journal
The FASEB Journal
Article Title
A novel exopolysaccharide, highly prevalent in marine Spongiibacter, triggers pyroptosis to exhibit potent anticancer effects
Article Publication Date
23-Jul-2025
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.